YARW SEC Filings | SEC Document SEARCH
Back to Search
Yarrow Bioscience, Inc. (YARW)
Ticker: YARW
CIK: 0001566044
45
Filings Found (Last 1 Year)
Filter Filings
All
8-K
2026. 9. 10.
Yarrow Bioscience, Inc. (YARW) (CIK 0001566044)
Current report
FORM 8-K
Open Filing
424B5
2026. 9. 11.
Yarrow Bioscience, Inc. (YARW) (CIK 0001566044)
Prospectus
424B5
Open Filing
424B5
2026. 9. 11.
Yarrow Bioscience, Inc. (YARW) (CIK 0001566044)
Prospectus
424B5
Open Filing
8-K
2026. 9. 10.
Yarrow Bioscience, Inc. (YARW) (CIK 0001566044)
Current report
FORM 8-K
Open Filing
10-Q
2026. 6. 30.
Yarrow Bioscience, Inc. (VYNE, YARW) (CIK 0001566044)
Quarterly report
10-Q
Open Filing
8-K/A
2026. 7. 24.
Yarrow Bioscience, Inc. (VYNE, YARW) (CIK 0001566044)
8-K/A
FORM 8-K/A
Open Filing
4
2026. 7. 29.
WONG RODERICK (CIK 0001493280)
Insider trading report
OWNERSHIP DOCUMENT
Open Filing
8-K
2026. 7. 29.
Yarrow Bioscience, Inc. (VYNE) (CIK 0001566044)
Current report
FORM 8-K
Open Filing
4
2026. 7. 27.
Ashiya Mona (CIK 0001794070)
Insider trading report
OWNERSHIP DOCUMENT
Open Filing
4
2026. 7. 27.
Zeronda Tyler (CIK 0001867033)
Insider trading report
OWNERSHIP DOCUMENT
Open Filing
8-K
2026. 7. 24.
Yarrow Bioscience, Inc. (VYNE) (CIK 0001566044)
Current report
FORM 8-K
Open Filing
4
2026. 7. 23.
Zeronda Tyler (CIK 0001867033)
Insider trading report
Open Filing
4
2026. 7. 23.
Harsch Mutya (CIK 0001727809)
Insider trading report
Open Filing
4
2026. 7. 23.
Domzalski David (CIK 0001727794)
Insider trading report
Open Filing
4
2026. 7. 23.
Stuart Iain (CIK 0001727756)
Insider trading report
Open Filing
8-K
2026. 7. 21.
VYNE Therapeutics Inc. (VYNE) (CIK 0001566044)
Current report
FORM 8-K
Open Filing
8-K
2026. 7. 16.
VYNE Therapeutics Inc. (VYNE) (CIK 0001566044)
Current report
FORM 8-K
Open Filing
8-K
2026. 7. 14.
VYNE Therapeutics Inc. (VYNE) (CIK 0001566044)
Current report
FORM 8-K
Open Filing
8-K
2026. 7. 10.
VYNE Therapeutics Inc. (VYNE) (CIK 0001566044)
Current report
FORM 8-K
Open Filing
4
2026. 6. 30.
Zeronda Tyler (CIK 0001867033)
Insider trading report
Open Filing
4
2026. 6. 30.
Harsch Mutya (CIK 0001727809)
Insider trading report
Open Filing
4
2026. 6. 30.
Domzalski David (CIK 0001727794)
Insider trading report
Open Filing
4
2026. 6. 30.
Stuart Iain (CIK 0001727756)
Insider trading report
Open Filing
4
2026. 5. 29.
Domzalski David (CIK 0001727794)
Insider trading report
Open Filing
8-K
2026. 5. 21.
VYNE Therapeutics Inc. (VYNE) (CIK 0001566044)
Current report
FORM 8-K
Open Filing
10-Q
2026. 3. 31.
VYNE Therapeutics Inc. (VYNE) (CIK 0001566044)
Quarterly report
10-Q
Open Filing
4
2026. 3. 31.
Zeronda Tyler (CIK 0001867033)
Insider trading report
Open Filing
4
2026. 3. 31.
Harsch Mutya (CIK 0001727809)
Insider trading report
Open Filing
4
2026. 3. 31.
Domzalski David (CIK 0001727794)
Insider trading report
Open Filing
4
2026. 3. 31.
Stuart Iain (CIK 0001727756)
Insider trading report
Open Filing
8-K
2026. 3. 11.
VYNE Therapeutics Inc. (VYNE) (CIK 0001566044)
Current report
FORM 8-K
Open Filing
10-K
2025. 12. 31.
VYNE Therapeutics Inc. (VYNE) (CIK 0001566044)
Annual report
10-K
Open Filing
8-K
2026. 1. 30.
VYNE Therapeutics Inc. (VYNE) (CIK 0001566044)
Current report
FORM 8-K
Open Filing
4
2025. 12. 31.
Zeronda Tyler (CIK 0001867033)
Insider trading report
Open Filing
4
2025. 12. 31.
Harsch Mutya (CIK 0001727809)
Insider trading report
Open Filing
4
2025. 12. 31.
Domzalski David (CIK 0001727794)
Insider trading report
Open Filing
4
2025. 12. 31.
Stuart Iain (CIK 0001727756)
Insider trading report
Open Filing
8-K
2025. 12. 17.
VYNE Therapeutics Inc. (VYNE) (CIK 0001566044)
Current report
FORM 8-K
Open Filing
4
2025. 12. 12.
Little Elisabeth Sandoval (CIK 0001632295)
Insider trading report
Open Filing
4
2025. 12. 12.
Basta Steven L (CIK 0001417397)
Insider trading report
Open Filing
4
2025. 12. 12.
BARBARI SHARON (CIK 0001240499)
Insider trading report
Open Filing
4
2025. 12. 12.
LEPORE PATRICK G (CIK 0001055404)
Insider trading report
Open Filing
8-K
2025. 12. 12.
VYNE Therapeutics Inc. (VYNE) (CIK 0001566044)
Current report
FORM 8-K
Open Filing
10-Q
2025. 9. 30.
VYNE Therapeutics Inc. (VYNE) (CIK 0001566044)
Quarterly report
10-Q
Open Filing
8-K
2025. 11. 6.
VYNE Therapeutics Inc. (VYNE) (CIK 0001566044)
Current report
8-K
Open Filing
Previous
Page 1 of 3
Next
